Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single intramu ...

Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an investigational vaccine-alternative monoclonal antibody ...

Forbes contributors publish independent expert analyses and insights. AI researcher working with the UN and others to drive social change. Dec 01, 2025, 07:08am EST Hacker. A man in a hoodie with a ...

Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts. The Beatles see both Anthology 4 and the Anthology Collection debut ...

FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

LONDON, Dec 1 (Reuters) - If White House adviser Kevin Hassett becomes President Donald Trump's pick to head the Federal Reserve from May, he will effectively serve as a "shadow Fed Chair" for five ...

Klaviyo, Inc. engages in the provision of a SaaS marketing platform. It offers personal ecommerce marketing reinvented for online stores on Shopify, Bigcommerce, and Magento. The company was founded ...

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, ...